ANXA5 and acute myeloid leukemia: Single drug treatment induced high levels of Annexin V+ cells (determined by Annexin V/PI staining and flow cytometry analyses) in all five AML cell lines and two of the three primary patient samples, with moderate activity in the third primary patient sample.